Indclav Bid 228 Dry Syrup: Effective Treatment for Bacterial Infections

Indclav Bid 228 Dry Syrup combines the power of Amoxycillin (200mg) with Clavulanic Acid (28.5mg) in a convenient, dry syrup formulation. This combination combats a wide range of bacterial infections by targeting both the causative agents and their resistance mechanisms.

This formulation is indicated for the treatment of:

* Upper respiratory tract infections: Including tonsillitis, pharyngitis, sinusitis, bronchitis, and otitis media.
* Lower respiratory tract infections: Including pneumonia, bronchiectasis, and bronchitis.
* Urinary tract infections: Including cystitis, pyelonephritis, and prostatitis.

Key Benefits:

* Broad-spectrum effectiveness: Combats various bacteria while inhibiting their development of resistance.
* Easy administration: Dry syrup formulation ensures precise dosage with ease of consumption.
* Precise dosing: Contains both amoxicillin and clavulanic acid in a controlled ratio for optimal efficacy.

Important Note: Always consult with your healthcare provider for diagnosis and appropriate treatment plan.